Search

everythinglearnresearchcommunity

for

Search:↓

The French Endocrine Society suggests diagnosing PCOS with two of three signs, recommends lifestyle changes and clomiphene for treatment, and calls for more research on certain treatments and tests.

Hair loss requires customized treatments based on its various causes and types.

Doctors should know how to diagnose and treat PCOS, which often involves checking for high male hormone levels and using medications to manage symptoms.

Continuous light exposure in rats leads to PCOS-like symptoms and suggests sleep habits might affect the disorder's development.

A team approach is crucial for managing PCOS, with dermatologists playing a key role.

People with Lichen Planus, especially with mucosal involvement, are more likely to have Metabolic Syndrome, which increases their risk for heart disease and diabetes.

Testosterone replacement may help post-menopausal women with androgen insufficiency, but more research is needed on its benefits and risks.

Hormonal treatments can improve acne, but they come with potential side effects and risks.

High-intensity interval training improves certain hormone levels and lipid profiles in women with PCOS.

Most cases of excessive hair growth in women are caused by polycystic ovarian syndrome and are linked to higher free testosterone levels.

Moderately high prolactin levels do not cause hair loss in women.

Unwanted facial hair significantly impacts over 40% of women's psychological and social well-being, and various treatment options are available.

Trilostane effectively treated hair loss in Alaskan Malamutes with no adverse effects.

The document concludes that treatments for female hair loss and excessive hair growth are temporary and not well-studied.

Insulin resistance is found in 20% of Thai women with PCOS, with age, waist size, skin changes, and abnormal blood fats increasing the risk.

Drugs for hormone-related conditions might help treat mental disorders but could have serious side effects.

Long pulsed Nd: YAG laser is safe and effective for long-term hair reduction in darker skin types.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

Low birthweight and rapid weight gain after birth may increase the risk of developing polycystic ovary syndrome.

5α-Reductase inhibitors do not consistently increase testosterone levels in the blood.

5-alpha reductase inhibitors can cause sexual, neurologic, endocrine, and cardiovascular side effects, but these are rare and usually stop after ending treatment.

The Free Androgen Index (FAI) is the best indicator of early hair loss in men before age 30.

Hair loss caused by longer latent hair cycle and sudden miniaturization, not gradual follicle size reduction.

Patients with RASopathies have a higher risk of autoimmune disorders and should be routinely screened.

Metformin improves early signs of heart disease in women with PCOS and raises apelin levels, but doesn't significantly change artery thickness.

Longer anogenital distance may indicate a higher chance of having polycystic ovary syndrome, and measuring this distance along with hormone levels could improve diagnosis.

Most acne patients were young males with face acne, with many experiencing worsening in summer and diet-related aggravation.

The document concludes that the risk of sexual side effects from 5-alpha-reductase inhibitors is low and often temporary, but more research is needed on potential permanent effects.

The document concludes that treatments for female hair loss and excess body hair are available, but managing expectations is important.

A pregnant woman's skin condition improved after giving birth, possibly due to high estrogen levels during pregnancy.